Login / Signup

HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?

Elisa GremeseAntonio GasbarriniGianfranco Ferraccioli
Published in: RMD open (2021)
Keyphrases
  • hepatitis b virus
  • cancer therapy
  • liver failure
  • rheumatoid arthritis patients
  • rheumatoid arthritis